BioNexus Gene Lab
BGLC
#11183
Rank
โ‚น0.22 B
Marketcap
โ‚น77.11
Share price
-9.43%
Change (1 day)
-81.41%
Change (1 year)

EPS for BioNexus Gene Lab (BGLC)

EPS in 2026 (TTM): -โ‚น96.73

According to BioNexus Gene Lab's latest financial reports the company's current EPS (TTM) is -โ‚น101.53. In 2025 the company made an earnings per share (EPS) of -โ‚น150.93 a decrease over its 2024 EPS that were of -โ‚น84.25.

EPS history for BioNexus Gene Lab from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น96.73-35.91%
2025-โ‚น150.9379.15%
2024-โ‚น84.25-45.96%
2023-โ‚น155.91260.87%
2022-โ‚น43.20-195.83%
2021โ‚น45.08-66.67%
2020โ‚น135.25-600.17%
2019-โ‚น27.04-1031.69%
2018โ‚น2.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น126.80 24.88%๐Ÿ‡บ๐Ÿ‡ธ USA